NCT07162324 A Multicenter, Prospective Study for Glioblastoma Patients Status NOT_YET_RECRUITING Phase N/A
NCT07145112 Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma Status RECRUITING Phase PHASE1
NCT07141732 Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy Status RECRUITING Phase PHASE1
NCT07134842 A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment. Status RECRUITING Phase PHASE1
NCT07121842 Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRI Status RECRUITING Phase NA
NCT07119294 Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study. Status RECRUITING Phase NA
NCT07100730 Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma Status RECRUITING Phase PHASE3
NCT07093814 A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma Status RECRUITING Phase PHASE1/PHASE2
NCT07089641 ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial Status RECRUITING Phase PHASE1
NCT07052877 The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab Status RECRUITING Phase N/A
NCT07047066 A Phase II Clinical Study to Evaluate the Efficacy and Safety of Flazoparib Combined With Temozolomide After the Completion of Standard Concurrent Chemoradiotherapy (CCRT) in Newly Diagnosed Glioblastoma Status NOT_YET_RECRUITING Phase PHASE2
NCT07042620 A Study to Test a New Fluid to Improve the Quality of Images Obtained by Using Sound Waves (Ultrasound) During Surgery Status ACTIVE_NOT_RECRUITING Phase NA
NCT07029100 Feasibility of ORGAnoids in Routine Clinical Practice for Molecular Analysis of the GLIOvascular Niche in Patients With Primary Brain Tumors. Status NOT_YET_RECRUITING Phase NA
NCT07003542 A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas Status RECRUITING Phase PHASE2
NCT06991101 Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma Status RECRUITING Phase PHASE2
NCT06975332 Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression Status RECRUITING Phase NA
NCT06973096 CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06964815 Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients Status RECRUITING Phase NA
NCT06936046 Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression Status RECRUITING Phase PHASE2